- Home
- ALV vs PEN Comparison
ALV vs PEN Comparison
Compare ALV & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALV
- PEN
- Stock Information
- Founded
- ALV 1953
- PEN 2004
- Country
- ALV Sweden
- PEN United States
- Employees
- ALV N/A
- PEN N/A
- Industry
- ALV Auto Parts:O.E.M.
- PEN Medical/Dental Instruments
- Sector
- ALV Consumer Discretionary
- PEN Health Care
- Exchange
- ALV Nasdaq
- PEN Nasdaq
- Market Cap
- ALV 7.7B
- PEN 7.0B
- IPO Year
- ALV 1997
- PEN 2015
- Fundamental
- Price
- ALV $97.83
- PEN $240.54
- Analyst Decision
- ALV Buy
- PEN Buy
- Analyst Count
- ALV 13
- PEN 14
- Target Price
- ALV $124.08
- PEN $232.23
- AVG Volume (30 Days)
- ALV 689.5K
- PEN 416.0K
- Earning Date
- ALV 10-18-2024
- PEN 10-30-2024
- Dividend Yield
- ALV 2.78%
- PEN N/A
- EPS Growth
- ALV 59.39
- PEN N/A
- EPS
- ALV 7.72
- PEN 0.89
- Revenue
- ALV $10,525,000,000.00
- PEN $1,163,776,000.00
- Revenue This Year
- ALV $1.14
- PEN $13.65
- Revenue Next Year
- ALV $4.49
- PEN $14.38
- P/E Ratio
- ALV $12.68
- PEN $270.46
- Revenue Growth
- ALV 4.63
- PEN 16.96
- 52 Week Low
- ALV $89.51
- PEN $148.00
- 52 Week High
- ALV $129.38
- PEN $277.34
- Technical
- Relative Strength Index (RSI)
- ALV 51.97
- PEN 66.76
- Support Level
- ALV $94.84
- PEN $234.62
- Resistance Level
- ALV $102.07
- PEN $242.95
- Average True Range (ATR)
- ALV 2.38
- PEN 6.55
- MACD
- ALV -0.20
- PEN -0.29
- Stochastic Oscillator
- ALV 47.65
- PEN 81.64
About ALV Autoliv Inc.
Autoliv is the global leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.